selected publications
- Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability. ACS medicinal chemistry letters. 2024 Academic Article GET IT
- Dual Strategy to Design New Agents Targeting Schistosoma mansoni: Advancing Phenotypic and SmCB1 Inhibitors for Improved Efficacy. ACS infectious diseases. 2024 Academic Article GET IT
- Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches. Journal of personalized medicine. 2024 Review GET IT
-
Next Generation of Fluorometric Protease Assays: 7-Nitrobenz-2-oxa-1,3-diazol-4-yl-amides (NBD-Amides) as Class-Spanning Protease Substrates.
Chemistry (Weinheim an der Bergstrasse, Germany).
2023
Academic Article
GET IT
Times cited: 2 - Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer. ChemMedChem. 2023 Academic Article GET IT
-
Identification, Characterization, and Synthesis of Natural Parasitic Cysteine Protease Inhibitors: Pentacitidins Are More Potent Falcitidin Analogues.
ACS chemical biology.
2022
Academic Article
GET IT
Times cited: 3 -
Novel Opportunities for Cathepsin S Inhibitors in Cancer Immunotherapy by Nanocarrier-Mediated Delivery.
Cells.
2020
Review
GET IT
Times cited: 30